ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2131

Younger Age and Female Gender Are the Main Determinants of Underestimation of Cardiovascular Risk in Rheumatoid Arthritis Patients

Calin Popa1,2, Alexander Rennings3, Alfons A. den Broeder4, Frank H.J. van den Hoogen4, Inger L. Meek1 and Jaap Fransen1, 1Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Rheumatology, Bernhoven Hospital, Uden, Netherlands, 3Internal Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 4Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Cardiovascular disease and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Rheumatoid Arthritis - Clinical Aspects III - Cardiovascular Disease and RA

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Rheumatoid arthritis (RA) patients have an increased cardiovascular (CV) risk. Current algorithms generally underestimate the risk in these patients [1]. In a meta-analysis, we have recently shown that younger RA patients bare the highest excess risk as compared to age-matched counterparts from the general population [2]. Objective: To investigate whether gender and age are contributing to the misclassification of CV risk in RA patients, when current risk algorithms developed for the general population are used. 

Methods: Prospectively collected data on cardiovascular risk factors and incident events from the Nijmegen inception cohort were analyzed, with up to 10 years follow-up [1]. Original as well as the EULAR modified (M_) SCORE algorithms were used to calculate the CV risk. Patients were stratified in deciles according to increasing risk and Hosmer-Lemeshow test was used to check concordance between observed and predicted risk, in subgroups based on gender and age.

Results: 863 prospectively followed RA patients were included in the analysis, 566 females and 297 males. During the first 10 years of follow-up 128 incident cardiovascular events had been recorded. In the whole group there was evidence of discrepancy between the predicted and observed CV risk (H-L test p<0.003) when the SCORE algorithm was applied. This mismatch was also present in the female subgroup (H-L test p<0.001), but it was less pronounced in males (H-L test p=0.09). Among the group of women who developed an event 40% had a predicted risk lower than 10% (corresponding to the low-risk group), whereas this was just 14 % in the RA males. When analyzing sub groups based on age, the H-L test p-values were: <55 years p<0.001, between 55 – 65 years p =0.93 and  >65 years p =0.96. The discrepancy between observed and predicted CV events in the youngest RA patients consisted mainly of underestimation of the CV risk (5.3% predicted vs. 8.0% observed). Similar results were obtained when the M_SCORE was applied. 

Conclusion: We report here in prospectively followed RA patients that CV risk is especially underestimated in women and younger patients. This suggests that modifying the weight for female gender and/or younger age in currently used CV risk algorithms might improve their predictive value in RA, contributing to better CV risk management in this group of patients. 

References

  1. Arts EE, Popa C et al. Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. Ann Rheum Dis 2015;74:668-74.
  2. Fransen J, Seyyed M, Bredie SJ, Popa CD. Rheumatoid arthritis disadvantages younger patients for cardiovascular diseases: a meta-analysis. EULAR 2015 [manuscript submitted for publication]

Disclosure: C. Popa, None; A. Rennings, None; A. A. den Broeder, None; F. H. J. van den Hoogen, None; I. L. Meek, None; J. Fransen, None.

To cite this abstract in AMA style:

Popa C, Rennings A, den Broeder AA, van den Hoogen FHJ, Meek IL, Fransen J. Younger Age and Female Gender Are the Main Determinants of Underestimation of Cardiovascular Risk in Rheumatoid Arthritis Patients [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/younger-age-and-female-gender-are-the-main-determinants-of-underestimation-of-cardiovascular-risk-in-rheumatoid-arthritis-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/younger-age-and-female-gender-are-the-main-determinants-of-underestimation-of-cardiovascular-risk-in-rheumatoid-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology